Practices in the Preclinical Safety Assessment of Peptides

Current Practices in the Preclinical Safety Assessment of Peptides 

A specific definition of what constitutes a peptide is difficult to find. Most people involved in developing biopharmaceuticals would define a peptide as 

Preclinical Safety Evaluation of Biopharmaceuticals A Science-Based Approach to Facilitating Clinical Trials, edited by Joy A. Cavagnaro Copyright 2008 by John Wiley Sons, Inc. 

TABLE 22.1 Overview of studies used to support peptide development 

Peptide Class Safety Pharmacology VChronic Toxicity Carcinogenicity Testing Genetic Toxicity Method of Manufacture Approval Date 

---